| Particulars |
|
|
|
| Company Name
| Piramal Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
1,329.25 |
B.V. (₹) |
58.30 |
| Sales(₹ Cr.) |
5,285.71 |
NP (₹ Cr.) |
690.16 |
| NP Var (%) |
78.00 |
Div% |
1.00 |
| CPS(₹) |
6.90 |
EPS (₹) |
5.20 |
| Traded Value(₹ Lakhs) |
2,146.61 |
52 Week High |
273.00 |
| 52 Week Low |
170.00 |
Price BSE |
175.00 |
| Price NSE |
174.00 |
Market Capital (₹ Cr.) |
23,195.38 |
| P/C Ratio |
25.50 |
P/E Ratio |
33.70 |
| Price Vs.BV |
3.00 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
1,127.26 |
| NP(₹ Cr.) |
196.33 |
NP Var % |
-7.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
4,897.03 |
| OPM |
18.78 |
NP |
642.75 |
| NP Var (%) |
9.77 |
EPS |
5.31 |
| PE |
32.86 |
|
|